Today, it’s important to monitor the following noteworthy stocks: Paytm, Adani Wilmar, ONGC, Lupin, and Kalyan Jewellers.

On December 26, 2023, stocks to keep an eye on are: Equity indices are expected to start trading again after the extended holiday break with a subdued tone as global cues continue to be lacklustre.


By 07:00 AM, the Nifty 50 was expected to have a steady or slightly positive beginning as Gift Nifty futures were quoted at 21,410.

Muthoot Microfin and Suraj Estate Developers are set to make their debuts on the stock market today. The first option was subscribed to up to 11.5 times, while the second option was subscribed to 15.7 times.

The big fintech company Paytm has rationalised its staff cost structure as a result of changes in its business that have occurred as a result of variations in regulatory posture and the implementation of artificial intelligence.

Kalyan Jewellers completely owns a step-down subsidiary in the United Arab Emirates. This firm is called Kalyan Jewellers Procurement LLC.

Anupam Rasayan has recently signed a significant agreement with a prominent Japanese multinational chemical company. The deal, valued at Rs 507 crore, involves the supply of cutting-edge polymer intermediates for a duration of 9 years.

Adani Green has recently signed a power purchase agreement (PPA) with the Solar Energy Corporation of India (SECI) to supply an impressive 1,799 megawatts (Mw) of solar power. Adani Green has now secured power purchase agreements totaling 19.8 GW.

ONGC: The company’s overseas subsidiary, ONGC Videsh, intends to generate funds of up to Rs 5,000 crore through non-convertible debentures (NCDs) to support capital expenditure, refinancing, and operational needs.

The United States Food and Drug Administration (US FDA) has finished a pre-approval inspection (PAI) at Aurobindo Pharma’s new injectable plant in East Windsor, New Jersey, according to a filing that the firm made with the exchange. The inspection yielded 10 procedural observations.

Adani Wilmar: In order to comply with the minimum public ownership standards established by Sebi, the promoters would sell down 1.24 percent of their investment. The divestment is scheduled to be completed by January 31, 2024.

Biocon Biologics, the pharmaceutical company’s division, has formed a partnership with Sandoz to distribute, sell, and promote Adalimumab in Japan. Adalimumab is a biosimilar version of the highly successful drug Humira.

Lupin: Lupin Atlantis Holdings, a wholly-owned subsidiary of Lupin, has signed an Asset Purchase Agreement with Sanofi, a French pharmaceutical company, with the purpose of acquiring a portfolio of accretive established goods in Europe and Canada. The brands AARANE in Germany and NALCROM in Canada and the Netherlands generated a combined turnover of approximately $6.494 million (Rs 53.7 crore) for FY23.

On Tuesday, the following stocks were prohibited from trading in futures and options: Ashok Leyland, Balrampur Chini, Delta Corp., Hindustan Copper, India Cements, National Aluminium, and SAIL. These stocks are excluded from trading in futures and options.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top
15 Plants That Look Like Animals | Animal-Like Flowers Bitcoin’s Strong Performance and U.S. Economic Data Banking dynasty member Jacob Rothschild died at 87. The Bengali Dishes Every Foodie Must Try When In Kolkata The bowlers with the most wickets in test cricket Most Expensive Crowns For Beauty Queens Best Trending Hairstyles for Indian Men in 2024 This season’s brides and grooms’ matching lehenga and sherwani ideas The fastest player to score 10,000 ODI runs The Best Dry Fruits for Weight Loss